Maria B. Chernysheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maria B. Chernysheva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Evgenii S. Ruchko
Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
2 shared publications - Andrey Valentinovich Vasiliev
Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
1 shared publication - Arthur Anatolievich Lee
Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
1 shared publication - Dmitry Alexandrovich Kashirskikh
Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
1 shared publication E. A. Suprunenko
Moscow State University
1 shared publication- Ekaterina Andreevna Vorotelyak
Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 8 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10003
Oral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia
Engineered bacteria are being explored as oral delivery systems for therapeutic peptides. This study examined Lactobacillus acidophilus expressing two GLP-1 peptide variants with N-terminal extensions, M-GLP-1 and M-6HIS-GLP-1, in male C57BL/6J mice with moderate streptozotocin (STZ)-induced hyperglycemia. Both purified peptides increased insulin concentrations in MIN6 conditioned medium after 24 h, but neither significantly attenuated the STZ-associated reduction in metabolic activity. Cage-level analysis showed lower average post-treatment glucose concentrations in mice receiving L. acidophilus expressing M-GLP-1 (Lacto-M-GLP-1) or M-6HIS-GLP-1 (Lacto-M-6HIS-GLP-1) than in STZ controls, but neither group differed significantly from mice receiving empty-vector L. acidophilus. The intraperitoneal glucose tolerance test showed numerically lower late-phase glucose concentrations and incremental area under the curve in both groups than in controls. Mice receiving Lacto-M-6HIS-GLP-1 showed greater body-weight change than those receiving Lacto-M-GLP-1 or empty-vector L. acidophilus. Pancreatic histology showed a lower pancreatic glucagon-positive signal area and a higher insulin-to-glucagon signal-area ratio than in STZ controls and Lacto-M-GLP-1. The findings demonstrate cellular responses to purified GLP-1 variants and metabolic changes associated with administering L. acidophilus expressing the peptides.
- 8 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10003
Open AccessOral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia
Engineered bacteria are being explored as oral delivery systems for therapeutic peptides. This study examined Lactobacillus acidophilus expressing two GLP-1 peptide variants with N-terminal extensions, M-GLP-1 and M-6HIS-GLP-1, in male C57BL/6J mice with moderate streptozotocin (STZ)-induced hyperglycemia. Both purified peptides increased insulin concentrations in MIN6 conditioned medium after 24 h, but neither significantly attenuated the STZ-associated reduction in metabolic activity. Cage-level analysis showed lower average post-treatment glucose concentrations in mice receiving L. acidophilus expressing M-GLP-1 (Lacto-M-GLP-1) or M-6HIS-GLP-1 (Lacto-M-6HIS-GLP-1) than in STZ controls, but neither group differed significantly from mice receiving empty-vector L. acidophilus. The intraperitoneal glucose tolerance test showed numerically lower late-phase glucose concentrations and incremental area under the curve in both groups than in controls. Mice receiving Lacto-M-6HIS-GLP-1 showed greater body-weight change than those receiving Lacto-M-GLP-1 or empty-vector L. acidophilus. Pancreatic histology showed a lower pancreatic glucagon-positive signal area and a higher insulin-to-glucagon signal-area ratio than in STZ controls and Lacto-M-GLP-1. The findings demonstrate cellular responses to purified GLP-1 variants and metabolic changes associated with administering L. acidophilus expressing the peptides.
- Open Access
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1424278
Development, regeneration, and physiological expansion of functional β-cells: Cellular sources and regulators
Pancreatic regeneration is a complex process observed in both normal and pathological conditions. The aim of this review is to provide a comprehensive understanding of the emergence of a functionally active population of insulin-secreting β-cells in the adult pancreas. The renewal of β-cells is governed by a multifaceted interaction between cellular sources of genetic and epigenetic factors. Understanding the development and heterogeneity of β-cell populations is crucial for functional β-cell regeneration. The functional mass of pancreatic β-cells increases in situations such as pregnancy and obesity. However, the specific markers of mature β-cell populations and postnatal pancreatic progenitors capable of increasing self-reproduction in these conditions remain to be elucidated. The capacity to regenerate the β-cell population through various pathways, including the proliferation of pre-existing β-cells, β-cell neogenesis, differentiation of β-cells from a population of progenitor cells, and transdifferentiation of non-β-cells into β-cells, reveals crucial molecular mechanisms for identifying cellular sources and inducers of functional cell renewal. This provides an opportunity to identify specific cellular sources and mechanisms of regeneration, which could have clinical applications in treating various pathologies, including in vitro cell-based technologies, and deepen our understanding of regeneration in different physiological conditions.
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1424278
Open AccessDevelopment, regeneration, and physiological expansion of functional β-cells: Cellular sources and regulators
Pancreatic regeneration is a complex process observed in both normal and pathological conditions. The aim of this review is to provide a comprehensive understanding of the emergence of a functionally active population of insulin-secreting β-cells in the adult pancreas. The renewal of β-cells is governed by a multifaceted interaction between cellular sources of genetic and epigenetic factors. Understanding the development and heterogeneity of β-cell populations is crucial for functional β-cell regeneration. The functional mass of pancreatic β-cells increases in situations such as pregnancy and obesity. However, the specific markers of mature β-cell populations and postnatal pancreatic progenitors capable of increasing self-reproduction in these conditions remain to be elucidated. The capacity to regenerate the β-cell population through various pathways, including the proliferation of pre-existing β-cells, β-cell neogenesis, differentiation of β-cells from a population of progenitor cells, and transdifferentiation of non-β-cells into β-cells, reveals crucial molecular mechanisms for identifying cellular sources and inducers of functional cell renewal. This provides an opportunity to identify specific cellular sources and mechanisms of regeneration, which could have clinical applications in treating various pathologies, including in vitro cell-based technologies, and deepen our understanding of regeneration in different physiological conditions.
- 1 July 2014
- Published by Allerton Press in Moscow University Biological Sciences Bulletin
- Vol. 69 (3) , 97-102
Pathological changes in the liver tissue of different aged mice with induced and physiological fibrosis
This paper presents the results of a study of developmental dynamics of pathological changes in the liver tissue of different aged mice with induced fibrosis, and also shows the role of melatonin as hepatoprotector. It was demonstrated that the toxic damage causes more severe pathological changes in the structure of liver tissue of old animals than of younger ones. The use of melatonin demonstrates a tendency to reduce the degree of liver fibrotization in young animals with induced fibrosis.
- 1 July 2014
- Published by Allerton Press in Moscow University Biological Sciences Bulletin
- Vol. 69 (3) , 97-102
Pathological changes in the liver tissue of different aged mice with induced and physiological fibrosis
This paper presents the results of a study of developmental dynamics of pathological changes in the liver tissue of different aged mice with induced fibrosis, and also shows the role of melatonin as hepatoprotector. It was demonstrated that the toxic damage causes more severe pathological changes in the structure of liver tissue of old animals than of younger ones. The use of melatonin demonstrates a tendency to reduce the degree of liver fibrotization in young animals with induced fibrosis.